Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Daniel Wolff, MD, PhD, of the University Hospital of Regensburg, Regensburg, Germany, talks about the developments that have been made in treating chronic GvHD and highlights areas for future progress.
Chronic GvHD therapy
